Axsome Therapeutics AXSM Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's other intangible assets—net?
- Axsome Therapeutics (AXSM) reported other intangible assets—net of $38.95M in Q1 2026.
- How has Axsome Therapeutics's other intangible assets—net changed year-over-year?
- Axsome Therapeutics's other intangible assets—net decreased by 14.1% year-over-year, from $45.32M to $38.95M.
- What is the long-term trend for Axsome Therapeutics's other intangible assets—net?
- Over 3 years (2022 to 2025), Axsome Therapeutics's other intangible assets—net has grown at a -12.1% compound annual growth rate (CAGR), from $59.66M to $40.52M.